kim alexander j

Patent Applications and Registrations

Patent applications and USPTO patent grants for kim alexander j.The latest application filed is for "novel tricyclic compounds as inhibitors of mutant idh enzymes".

Company Profile

7.9.10

- unknown
Kim; Alexander J. - Rahway NJ
Kim; Alexander J. - Eastvale CA US
Kim; Alexander J. - Morganville NJ
Kim; Alexander J. - Levittown PA
Kim; Alexander J. - Philadelphia PA
Kim; Alexander J - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Handheld surgical device having retractable portion Grant 10695075 -	2020-06-30
Amalgam electrode, producing method thereof, and method of electrochemical reduction of carbon dioxide using the same Grant 10689768 -	2020-06-23
Post-tension concrete leave out splicing system and method Grant 10689853 -	2020-06-23
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,508,108 - Fischer , et al. Dec	2019-12-17
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,442,819 - Fischer , et al. Oc	2019-10-15
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,086,000 - Fischer , et al. October 2, 2	2018-10-02
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170369507 - Christian; Fischer ; et al.	2017-12-28
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170362220 - Fischer; Christian ; et al.	2017-12-21
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170360800 - Fischer; Christian ; et al.	2017-12-21
Cyclic amine substituted heterocyclic CETP inhibitors Grant 9,353,101 - Acton, III , et al. May 31, 2	2016-05-31
Cyclic Amine Substituted Heterocyclic Cetp Inhibitors App 20150111866 - Acton, III; John J. ; et al.	2015-04-23
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents Grant 8,796,258 - Anand , et al. August 5, 2	2014-08-05
Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-diabetic Agents App 20130123237 - Anand; Rajan ; et al.	2013-05-16
Alkylquinoline and alkylquinazoline kinase modulators Grant 8,071,768 - Baindur , et al. December 6, 2	2011-12-06
Aminoquinoline And Aminoquinazoline Kinase Modulators App 20070004763 - Baindur; Nand ; et al.	2007-01-04
Alkylquinoline And Alkylquinazoline Kinase Modulators App 20060281772 - Baindur; Nand ; et al.	2006-12-14
Substituted 1,4-benzodiazepines and uses thereof App 20060148792 - Lu; Tianbao ; et al.	2006-07-06
Substituted 1,4-benzodiazepines and uses thereof Grant 7,067,512 - Lu , et al. June 27, 2	2006-06-27
Substituted 1,4-benzodiazepines and uses thereof App 20030109518 - Lu, Tianbao ; et al.	2003-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.